The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study.
The authors carried out a door-to-door survey to determine the prevalence of epilepsy among 55,000 people in China. The lifetime prevalence was 7.0/1000, and 41% of all persons had never received appropriate treatment. The prevalence of active epilepsy was 4.6/1000, and 63% of people with active epilepsy had not received antiepileptic treatment in the week before the survey. Figures for the prevalence and the treatment gap were significantly higher than previous estimates.
Department of Neuroepidemiology, Beijing Neurosurgical Institute, PRC. qgnfbwwz@public.bta.net.cn
W Z
WZ
Wang
J Z
JZ
Wu
D S
DS
Wang
X Y
XY
Dai
B
B
Yang
T P
TP
Wang
C L
CL
Yuan
R A
RA
Scott
L L
LL
Prilipko
H M
HM
de Boer
J W
JW
Sander
D000927:Anticonvulsants / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D004363:Drug Utilization / Q000706:statistics & numerical data; D004827:Epilepsy / Q000188:drug therapy / Q000453:epidemiology*; D006306:Health Surveys; D006801:Humans; D015995:Prevalence; D012494:Sampling Studies; D014944:World Health Organization
D000927:Anticonvulsants